Briev
Live
Politics

Pentagon's New Testosterone Testing Plan Sparks Debate Over Masculinity and Military Policy

Defense Secretary Pete Hegseth unveiled a program to screen service members for low testosterone and offer replacement therapy, prompting criticism that it reinforces harmful gender stereotypes.

Defense Secretary Pete Hegseth announced a new initiative to add testosterone measurements to regular health exams for military personnel and to provide testosterone replacement therapy to those with low levels, claiming it would enhance combat effectiveness. The program, presented in a video called “High T Department of War,” was swiftly challenged by journalists and scientists who highlighted the difficulty of accurately measuring hormone levels and the lack of consensus on when therapy is appropriate.

Observers such as Rebecca Jordan-Young and Carole Hooven argue the policy reinforces a reductive link between testosterone, aggression, and masculinity, echoing longstanding cultural myths. Media commentary, including one outlet's segment warning that boosted testosterone could turn soldiers into “wild animals,” underscores the gendered rhetoric. While urologists like Tobias Kohler see minimal risk and note that men generally receive fewer routine health checks, they also cite possible side effects like reduced sperm production and dependence on external hormones.

The move coincides with a surge in consumer testosterone clinics and telehealth services that market the hormone as a panacea for fatigue, low libido, and aging, further blurring scientific evidence and cultural ideology. Critics warn that the policy’s symbolic message may outweigh any individual health benefits, especially as it contrasts with ongoing restrictions on transgender service members.

Why it matters

The plan could reshape military health policy while reinforcing gender stereotypes that affect service culture.

In this story

testosterone testingmilitary healthmasculinity stereotypestestosterone replacement therapypentagon policygender biastelehealth clinicshormone marketing